# N, N-Dimethyl-4-Aminopyridine- and Aluminum Isopropoxide-Catalysed Ring-Opening Polymerizations of β-Butyrolactone for the Antimicrobial Oligohydroxybutyrate

**Authors:** Qi Bao, Pui-Kin So, Siu Lun Leung, Polly Hang-Mei Leung, Xiaoming Tao

PMC · DOI: 10.3390/ijms27020999 · 2026-01-19

## TL;DR

This study shows that PHB oligomers made from β-butyrolactone can quickly and effectively kill bacteria and viruses, making them promising for use in disinfectants and antiseptics.

## Contribution

The paper introduces a novel catalytic method for producing PHB oligomers with strong antimicrobial and antiviral properties.

## Key findings

- PHB oligomers showed >95% inhibition against influenza and SARS-CoV-2 within 20 minutes.
- They exhibited broad-spectrum antibacterial activity against E. coli and S. aureus.
- Structural analysis confirmed terminal hydroxyl group loss during polymerization.

## Abstract

Infectious pathogens pose serious threats to public health, necessitating the development of more antimicrobials. In this study, oligohydroxybutyrates were obtained through the catalyzed polymerization of β-butyrolactone using N, N-dimethyl-4-aminopyridine (DMAP) and aluminum isopropoxide [Al(OiPr)3] and applied as sustainable antimicrobial agents. The poly3-hydroxybutyrate (PHB) oligomers exhibited broad-spectrum antibacterial activities against both Gram-negative (E. coli) and Gram-positive (S. aureus) model bacteria. Additionally, PHB oligomers displayed robust (inhibiting rate: >95%) and rapid (action time: <20 min) antiviral activity against three notorious single-stranded RNA viruses, that is, influenza A virus (H1N1 and H3N2) and coronavirus (SARS-CoV-2). In particular, a comprehensive set of advanced experimental characterizations, including FT-IR, 1H- and 13C-NMR, and H-ESI-MS/MS, was applied to analyze their chemical structures. The results confirmed the loss of terminal hydroxyl groups in the PHB intermediate and end products associated with theoretical calculations. These findings will also help provide deep insight into the major chain growth mechanism during the synthesis of PHB. The structural variations, which were treated as unwanted side reactions, were identified as a pivotal factor by deactivating the terminal hydroxy during chain growth. Their effective sterilization properties and degradability endowed the as-prepared PHB oligomers with a promising biomedical potential, including for use as disinfectants, sanitizers, and antiseptics.

## Linked entities

- **Chemicals:** N, N-dimethyl-4-aminopyridine (PubChem CID 14284), aluminum isopropoxide (PubChem CID 11143), β-butyrolactone (PubChem CID 18303)

## Full-text entities

- **Diseases:** Infectious (MESH:D003141)
- **Chemicals:** beta-Butyrolactone (MESH:C013426), H (MESH:D006859), 13C (MESH:C000615229), 1H (-), PHB (MESH:C003182), N, N-Dimethyl-4-Aminopyridine (MESH:C003885)
- **Species:** H1N1 subtype (serotype) [taxon 114727], H3N2 subtype (serotype) [taxon 119210], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Gammacoronavirus (genus) [taxon 694013], Escherichia coli (E. coli, species) [taxon 562], Influenza A virus (no rank) [taxon 11320]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12842008/full.md

---
Source: https://tomesphere.com/paper/PMC12842008